Genmab | GEN - Market Capitalization


Genmab reported DKK218.61B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agios Pharmaceuticals USD 1.61B 598M Nov/2026
Almirall EUR 2.3B 150.98M Nov/2026
Amarin USD 290M 51M Dec/2025
Amgen USD 247.94B 20.06B Nov/2026
argenx SE USD 60.01B 2.38B Sep/2026
AstraZeneca USD 213.88B 23.43B Nov/2026
Bayer EUR 52.42B 5.31B Nov/2026
BioMarin Pharmaceutical USD 10.68B 936M Nov/2026
Demant DKK 83.1B 26.31B Nov/2026
Exelixis USD 19.82B 5.34B Nov/2026
Fresenius Medical Care EUR 12.06B 1.43B Nov/2026
Genmab DKK 17.1B 88.06B Jun/2026
GlaxoSmithKline GBP 74.11B 6.03B Sep/2026
GN Store Nord DKK 17.65B 1.52B Nov/2026
GRIFOLS EUR 4.76B 1.02B Nov/2026
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Insmed USD 24.93B 1.82B Sep/2026
Lakefront Biotherapeutics EUR 1.97B 239.87M Nov/2026
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 64.74B 46.89B Nov/2026
Novartis USD 292.09B 51.5B Sep/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 100.56B 13.53B Nov/2026
UCB EUR 46.41B 13.94B Dec/2025